Mutation analysis of genes that control the GI/S cell cycle in melanoma: TP53, CDKNIA, CDKN2A, and CDKN2B

Keyphrases

• Melanoma 100%
• Tumor Protein p53 (TP53) 100%
• SCell 100%
• CDKN2B 100%
• Cyclin-dependent Kinase Inhibitor 2A (CDKN2A) 100%
• Melanocytic Tumor 100%
• Mutation Analysis 100%
• TP53 Gene 66%
• Melanoma Cells 66%
• Stop Codon mutation 33%
• Single nucleotide Polymorphism 33%
• Sigma Phase 33%
• Metastatic Melanoma 33%
• Tumorigenesis 33%
• Skin Melanoma 33%
• Exon 1 33%
• Tumor Cell Lines 33%
• Conformational Polymorphism 33%
• Method of Lines 33%
• Tumorigenesis Mechanism 33%
• Missense mutation 33%
• CDKN2A Gene 33%
• Melanoma Tumor Cells 33%
• Suppressor Genes 33%
• CDKN2B Gene 33%
• Primary Melanoma 33%
• CDKN1A 33%
• Exon 10 33%
• Single-point mutation 33%

Biochemistry, Genetics and Molecular Biology

• Intron 100%
• Cell Cycle 100%
• S Cell 100%
• CDKN2B 100%
• Exon 40%
• Carcinogenesis 40%
• Stop Codon 20%
• Single-Nucleotide Polymorphism 20%
• Point Mutation 20%
• S Phase 20%
• Missense Mutation 20%
• Suppressor Gene 20%